Phase II, Single Arm, Open Label, Single Center Study of Obinutuzumab and Ibrutinib in the Front Line Treatment of Indolent B-Cell Non-Hodgkin Lymphomas

Nicholas Kendsersky,Rebecca Masel, Amman Bhasin,Tingting Zhan, Carol Gung,Mercy George,Frederick Michael Fellin,Allison Zibelli, Avnish Bhatia, Rajan Singla,Michael Ramirez,Andrew E. Chapman,Patrick Mille, Cassandra Thomas, Joanne Filicko-O'Hara,Barbara Pro,Onder Alpdogan,Adam F. Binder,Pierluigi Porcu, Andres Ferber, Sameh Gaballa, Ubaldo Martinez Outschoorn

BLOOD(2023)

引用 0|浏览6
暂无评分
摘要
Background:
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要